Molbio Diagnostics LimitedMOLBIOCorporate

Medical Devices Latest results: Jun 2026 3 quarters of data

₹1,259.70

MCap ₹14,517 Cr

Molbio Diagnostics Limited — Stock analysis & AI research Molbio Diagnostics Limited — Seasonality — best & worst months Molbio Diagnostics Limited — Technical indicators & charts Molbio Diagnostics Limited — Live exchange announcements

📋 Small Cap Stocks List 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹399 Cr

Sales · Jun 2026

+299.4% YoY

₹92 Cr

Operating Profit · Jun 2026

+672.7% YoY

22.9%

OPM % · Jun 2026

+243.1% YoY

₹57 Cr

Net Profit · Jun 2026

+335.9% YoY

₹5.02

EPS · Jun 2026

+147.8% YoY

📝 Molbio Diagnostics Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Molbio Diagnostics Limited reported revenue of ₹399 crore for the quarter ended June 2026 (Q1 FY27), up 299.4% from ₹100 crore in the same quarter last year, and down 28.8% sequentially over the March 2026 quarter.

The company swung to a net profit of ₹57 crore from a net loss of ₹24 crore a year earlier. Earnings per share (EPS) came in at ₹5.02.

Operating profit stood at ₹92 crore — an operating margin (OPM) of 22.9%, compared with -16.0% in the year-ago quarter.

Valuation snapshot

At the current price of ₹1,259.70, MOLBIO has a market capitalisation of ₹14,517 crore.

Shareholding pattern

As of Sep 2026, promoters held 41.29%, foreign institutional investors (FIIs) 1.59%, domestic institutional investors (DIIs) 19.08%, public shareholders 38.03% of Molbio Diagnostics Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹14,517 Cr

Current Price ?

₹1,259.7

P/E ?

N/A

Industry P/E ?

N/A

P/B ?

N/A

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹399 Cr

PAT — latest qtr ?

₹57 Cr

YoY qtr sales growth ?

299.4%

YoY qtr profit growth ?

335.9%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

41.29%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

20.9%

Return 6 months ?

20.9%

🗓️ Quarterly results (3 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Jun 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	100	561	399	+299.4%	-28.8%
Operating Profit	-16	159	92	+672.7%	-42.4%
Other Income	1	5	1	+36.8%	-72.6%
Interest	4	12	9	+116.6%	-27.8%
Depreciation	12	20	8	-29.9%	-57.9%
Profit Before Tax	-31	132	76	+344.9%	-42.5%
Net Profit	-24	96	57	+335.9%	-41.0%
EPS	-10.51	8.06	5.02	+147.8%	-37.7%
OPM %	-16.0%	28.3%	22.9%	+243.1%	-19.1%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

👥 Shareholding (latest 1 periods)

Metric	Sep 2026	% Chg
Promoters	41.29%	—
FIIs	1.59%	—
DIIs	19.08%	—
Public	38.03%	—
No. of Shareholders	50,395	—

⚖️ Peer comparison

Peer comparison unavailableNo other companies in our database share this industry/sector yet.

❓ Frequently asked questions

What was Molbio Diagnostics Limited's revenue in Q1 FY27?

What was Molbio Diagnostics Limited's net profit in Q1 FY27?